Ignite Creation Date:
2024-05-05 @ 6:36 PM
Last Modification Date:
2024-10-26 @ 9:35 AM
Study NCT ID:
NCT00514657
Status:
COMPLETED
Last Update Posted:
2007-08-10
First Post:
2007-08-09
Brief Title:
Trial in Periodontal Tissue Regeneration Using Fibroblast Growth Factor-2
Sponsor:
Kaken Pharmaceutical
Organization:
Kaken Pharmaceutical
Study Overview
Official Title:
Trial in Periodontal Tissue Regeneration Using Fibroblast Growth Factor-2 Randomised Controlled Phase II Clinical Trial
Status:
COMPLETED
Status Verified Date:
2007-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The present clinical trial clarified that basic fibroblast growth factor-2 FGF-2 can induce regeneration of periodontal tissue lost by progression of periodontitis and evaluated the safety of such induction
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None